Smith Robert Joseph bought CTXR
March 14, 2024 · Form 4 insider transaction
Smith Robert Joseph bought 75,000 shares of Citius Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderSmith Robert Joseph
Role—
SecurityStock Option (Right to Purchase Common Stock)
Transaction codeA: Grant or award
Transaction dateMarch 14, 2024
Filing dateMarch 18, 2024
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted on March 14, 2024, with a Vesting Commencement Date of March 12, 2024, the date of the Optionee's election to the Board of the Company. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.